Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs (Q27618667)

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better?

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

1 reference

7 January 2021

The rationale for E2020 as a potent acetylcholinesterase inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Conformational analyses and molecular-shape comparisons of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Atomic Structure of Acetylcholinesterase from Torpedo californica : A Prototypic Acetylcholine-Binding Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Huperzine A, a novel promising acetylcholinesterase inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

5,7-Dihydro-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-6H-pyrrolo[3,2-f]-1,2-benzisoxazol-6-one: A Potent and Centrally-Selective Inhibitor of Acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Prediction of the binding site of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine in acetylcholinesterase by docking studies with the SYSDOC program

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Primary structure of Torpedo californica acetylcholinesterase deduced from its cDNA sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

The X-ray Structure of a Transition State Analog Complex Reveals the Molecular Origins of the Catalytic Power and Substrate Specificity of Acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Aromatic rings act as hydrogen bond acceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Amino-aromatic interactions in proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

The simulated binding of (+/-)-2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]meth yl] -1H-inden-1-one hydrochloride (E2020) and related inhibitors to free and acylated acetylcholinesterases and corresponding structure-activity analyse

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Stereochemistry of charged nitrogen-aromatic interactions and its involvement in ligand-receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Acetylcholinesterase: role of the enzyme's charge distribution in steering charged ligands toward the active site

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Conformation gating as a mechanism for enzyme specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Clinical pharmacokinetics: current requirements and future perspectives from a regulatory point of view

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Enantioselective drug analysis: problems and resolutions

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Cryocrystallography of biological macromolecules: a generally applicable method

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Crystallographic R factor refinement by molecular dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

Efficient rebuilding of protein structures.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

PROCHECK: a program to check the stereochemical quality of protein structures

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

WHAT IF: a molecular modeling and drug design program

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

SURFNET: a program for visualizing molecular surfaces, cavities, and intermolecular interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2899%2980040-9

7 January 2021

10.1016/S0969-2126(99)80040-9

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_zviy3y44lrcq7el5epz2vnttam

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zviy3y44lrcq7el5epz2vnttam

24 November 2022

mapped directly with Wikidata item

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

10368299

1 reference

Consolidated OpenCitations Corpus – April 2017